1. Home
  2. MNKD vs CODI Comparison

MNKD vs CODI Comparison

Compare MNKD & CODI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MNKD
  • CODI
  • Stock Information
  • Founded
  • MNKD 1991
  • CODI 2005
  • Country
  • MNKD United States
  • CODI United States
  • Employees
  • MNKD N/A
  • CODI N/A
  • Industry
  • MNKD Biotechnology: Pharmaceutical Preparations
  • CODI Home Furnishings
  • Sector
  • MNKD Health Care
  • CODI Consumer Discretionary
  • Exchange
  • MNKD Nasdaq
  • CODI Nasdaq
  • Market Cap
  • MNKD 1.9B
  • CODI 1.6B
  • IPO Year
  • MNKD 2004
  • CODI 2006
  • Fundamental
  • Price
  • MNKD $6.01
  • CODI $21.49
  • Analyst Decision
  • MNKD Buy
  • CODI Strong Buy
  • Analyst Count
  • MNKD 6
  • CODI 3
  • Target Price
  • MNKD $8.92
  • CODI $29.00
  • AVG Volume (30 Days)
  • MNKD 2.7M
  • CODI 199.0K
  • Earning Date
  • MNKD 02-25-2025
  • CODI 02-26-2025
  • Dividend Yield
  • MNKD N/A
  • CODI 4.65%
  • EPS Growth
  • MNKD N/A
  • CODI 38.85
  • EPS
  • MNKD 0.08
  • CODI 0.56
  • Revenue
  • MNKD $267,200,000.00
  • CODI $2,216,497,000.00
  • Revenue This Year
  • MNKD $45.45
  • CODI $12.78
  • Revenue Next Year
  • MNKD $16.45
  • CODI $9.73
  • P/E Ratio
  • MNKD $75.81
  • CODI $38.62
  • Revenue Growth
  • MNKD 51.35
  • CODI 16.71
  • 52 Week Low
  • MNKD $3.17
  • CODI $19.76
  • 52 Week High
  • MNKD $7.63
  • CODI $25.07
  • Technical
  • Relative Strength Index (RSI)
  • MNKD 37.75
  • CODI 37.31
  • Support Level
  • MNKD $5.98
  • CODI $21.11
  • Resistance Level
  • MNKD $6.32
  • CODI $21.89
  • Average True Range (ATR)
  • MNKD 0.21
  • CODI 0.53
  • MACD
  • MNKD -0.04
  • CODI -0.13
  • Stochastic Oscillator
  • MNKD 20.55
  • CODI 29.24

About MNKD MannKind Corporation

MannKind Corp is a biopharmaceutical company focused on the development and commercialization of inhaled therapeutic products for patients with diseases such as diabetes and pulmonary arterial hypertension. Its approved product, Afrezza (insulin human) Inhalation Powder, is an ultra-rapid-acting inhaled insulin used to improve glycemic control in adults with diabetes. The product consists of a dry powder formulation of human insulin delivered from a small portable inhaler.

About CODI D/B/A Compass Diversified Holdings Shares of Beneficial Interest

Compass Diversified Holdings is a diversified business conglomerate based in the United States having two groups: branded consumer business and industrial business. Branded consumer businesses are characterized as those businesses that capitalize on a valuable brand name in their respective market sector. It includes 5.11, Ergobaby, Liberty Safe, and Velocity Outdoor. Industrial businesses are characterized as those businesses that focus on manufacturing and selling particular products and industrial services within a specific market sector. The company has operations in the United States, Canada, Europe, Asia Pacific, and other International areas.

Share on Social Networks: